Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Coherus BioSciences Inc
NASDAQ:CHRS

Watchlist Manager
Coherus BioSciences Inc Logo
Coherus BioSciences Inc
NASDAQ:CHRS
Watchlist
Price: 2.22 USD Market Closed
Market Cap: $268.3m
Write Note Create Alert Ask AI

Intrinsic Value

The intrinsic value of one CHRS stock under the Base Case scenario is 1.44 USD. Compared to the current market price of 2.22 USD, Coherus BioSciences Inc is Overvalued by 35%.

Valuation Methods:
DCF Value
N/A
Relative Value
$1.44
DCF Value
N/A
Relative Value
$1.44
CHRS Intrinsic Value
1.44 USD
Overvaluation 35%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Coherus BioSciences Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about CHRS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CHRS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Coherus BioSciences Inc.

Explain Valuation
Compare CHRS to

Fundamental Analysis

CHRS Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
profitability
Score

CHRS Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
solvency
Score
Coherus BioSciences Inc
NASDAQ:CHRS
US
Biotechnology
Market Cap
268.3m USD
IPO
Nov 6, 2014
US
Biotechnology
Market Cap
268.3m USD
IPO
Nov 6, 2014
Price
$
$
|
How do you feel about CHRS?
Bearish
Neutral
Bullish
Financials
Efficiency

Free Cash Flow Analysis
Coherus BioSciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Wall St
Price Targets

CHRS Price Targets Summary
Coherus BioSciences Inc

Wall Street analysts forecast CHRS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CHRS is 5.78 USD with a low forecast of 4.04 USD and a high forecast of 7.35 USD.

CHRS Lowest Forecast
Wall Street Target
4.04 USD
82% Upside
CHRS Average Forecast
Wall Street Target
5.78 USD
160% Upside
CHRS Highest Forecast
Wall Street Target
7.35 USD
231% Upside
Lowest
Price Target
4.04 USD
82% Upside
Average
Price Target
5.78 USD
160% Upside
Highest
Price Target
7.35 USD
231% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Coherus BioSciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CHRS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
= Dividend Yield
+ Buyback Yield
+ Debt Paydown Yield
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CHRS Insider Trading
Buy and sell transactions by insiders

See Also

Summary
CHRS intrinsic value, competitors valuation, and company profile.
DCF Valuation
CHRS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CHRS stock valuation using valuation multiples.
Wall Street Estimates
CHRS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CHRS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is the Intrinsic Value of one CHRS stock?

The intrinsic value of one CHRS stock under the Base Case scenario is 1.44 USD.

Is CHRS stock undervalued or overvalued?

Compared to the current market price of 2.22 USD, Coherus BioSciences Inc is Overvalued by 35%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 315,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.